Prinovox 250 mg + 62.5 mg spot-on solution for large dogs
Prinovox 250 mg + 62.5 mg spot-on solution for large dogs
Authorised
- Moxidectin
- Imidacloprid
Product identification
Medicine name:
Prinovox 250 mg + 62.5 mg spot-on solution for large dogs
PRINOVOX
Active substance:
- Moxidectin
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Moxidectin62.50milligram(s)2.50millilitre(s)
-
Imidacloprid250.00milligram(s)2.50millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Package description:
- (ID6): 1 unspecified outer container with 21 Pipette (PolyPropylene) with 2.5 millilitre(s) (52.5 millilitre(s))
- (ID5): 1 unspecified outer container with 6 Pipette (PolyPropylene) with 2.5 millilitre(s) (15.0 millilitre(s))
- (ID4): 1 unspecified outer container with 4 Pipette (PolyPropylene) with 2.5 millilitre(s) (10.0 millilitre(s))
- (ID3): 1 unspecified outer container with 3 Pipette (PolyPropylene) with 2.5 millilitre(s) (7.5 millilitre(s))
- (ID2): 1 unspecified outer container with 2 Pipette (PolyPropylene) with 2.5 millilitre(s) (5.0 millilitre(s))
- (ID1): 1 unspecified outer container with 1 Pipette (PolyPropylene) with 2.5 millilitre(s) (2.5 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Italia S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- Ministry Of Health
Authorisation number:
- 105081
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0196/005
Concerned member states:
-
Ireland
-
Italy
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 15/02/2022
How useful was this page?: